While UnitedHealth has suffered badly from multiple headwinds, contrarians have a case for a near-term recovery in UNH stock.

UnitedHealth's top-line growth remains strong despite cost pressures impacting FY2025 earnings. Click here to find out why I initiated UNH stock as a buy.

UNH's stock plunge seems to be overdone, with current prices reflecting worst-case scenarios from potential DOJ probes ... case will likely lead to a strong recovery in a relatively short time.

UnitedHealth Group ($UNH) is drawing attention from traders after a spike in call option activity and notable insider buying.

Piper Sandler sharply lowered its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $353 from $552, while ...

If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: The Best and Worst Dow Stocks ...

Further, he expects recovery could be delayed into 2026-27, especially as Medicaid funding cuts hurt profitability in Medicare Advantage. Turning to Wall Street, UNH stock has a Strong Buy ...

UnitedHealth (NYSE:UNH) was among the biggest ... sells medical devices and instruments. The stock declined significantly two weeks ago, and despite a recovery, it is still down 17%.

UnitedHealth shares slid in recent trading Thursday after tumbling Wednesday amid worries about potential cuts to Medicaid and Medicare, and a report accusing the insurer of paying secret bonuses to ...

DOJ is reportedly investigating UnitedHealth for potential criminal Medicare fraud ... UnitedHealth Group Inc. UNH stock is trading lower on Thursday in reaction to a media report on a possible ...